Achieve Life Valuation
| ACHV Stock | USD 4.29 0.04 0.92% |
At this time, the firm appears to be undervalued. Achieve Life Sciences shows a prevailing Real Value of $10.41 per share. The current price of the firm is $4.29. Our model approximates the value of Achieve Life Sciences from analyzing the firm fundamentals such as return on equity of -1.86, and Current Valuation of 114.47 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Achieve Life's valuation include:
Price Book 4.7018 | Enterprise Value 114.5 M | Enterprise Value Ebitda (2.42) |
Undervalued
Today
Please note that Achieve Life's price fluctuation is not too volatile at this time. Calculation of the real value of Achieve Life Sciences is based on 3 months time horizon. Increasing Achieve Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Achieve stock is determined by what a typical buyer is willing to pay for full or partial control of Achieve Life Sciences. Since Achieve Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Achieve Stock. However, Achieve Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.29 | Real 10.41 | Target 28.57 | Hype 4.3 | Naive 4.18 |
The intrinsic value of Achieve Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Achieve Life's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Achieve Life Sciences helps investors to forecast how Achieve stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Achieve Life more accurately as focusing exclusively on Achieve Life's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Achieve Life's intrinsic value based on its ongoing forecasts of Achieve Life's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Achieve Life's closest peers.
Achieve Life Cash |
|
Achieve Valuation Trend
Analysing the historical paterns of Achieve Life's enterprise value and its market capitalization is a good way to estimate and gauge the value of Achieve Life Sciences over time and is usually enough for investors to make rational market timing decisions.
Achieve Life Total Value Analysis
Achieve Life Sciences is presently forecasted to have valuation of 114.47 M with market capitalization of 147.53 M, debt of 16.73 M, and cash on hands of 29.38 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Achieve Life fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
114.47 M | 147.53 M | 16.73 M | 29.38 M |
Achieve Life Asset Utilization
One of the ways to look at asset utilization of Achieve is to check how much profit was generated for every dollar of assets it reports. Achieve Life Sciences shows a negative utilization of assets of -0.54 percent, losing $0.005409 for each dollar of assets held by the firm. Unsuccessful asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Achieve Life Sciences shows how unproductive it operates for each dollar spent on its assets.Achieve Life Ownership Allocation
Achieve Life holds a total of 34.39 Million outstanding shares. Over half of Achieve Life's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Achieve Life Profitability Analysis
Net Loss for the year was (29.82 M) with profit before overhead, payroll, taxes, and interest of 0.About Achieve Life Valuation
Our relative valuation model uses a comparative analysis of Achieve Life. We calculate exposure to Achieve Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Achieve Life's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -228 K | -216.6 K | |
| Pretax Profit Margin | (3.58) | (3.76) | |
| Operating Profit Margin | (3.77) | (3.96) | |
| Net Loss | (3.58) | (3.76) | |
| Gross Profit Margin | 0.46 | 0.49 |
Achieve Life Growth Indicators
Investing in growth stocks can be very risky. If the company such as Achieve Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 19.8 M |
Achieve Life Current Valuation Indicators
Achieve Life's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Achieve Life's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Achieve Life, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Achieve Life's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Achieve Life's worth.Additional Tools for Achieve Stock Analysis
When running Achieve Life's price analysis, check to measure Achieve Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achieve Life is operating at the current time. Most of Achieve Life's value examination focuses on studying past and present price action to predict the probability of Achieve Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Achieve Life's price. Additionally, you may evaluate how the addition of Achieve Life to your portfolios can decrease your overall portfolio volatility.